Targeting KRAS Mutations in Advanced NSCLC

home / precision-medicine / targeting-kras-mutations-in-advanced-nsclc

Shared insight on recent advances in KRAS-mutant NSCLC, with a focus on new therapies on the horizon.

Evolution of Targeted Therapy in Advanced NSCLC

EP. 1: Evolution of Targeted Therapy in Advanced NSCLC

Targeted Oncology
May 27th 2020

Watch

Targeted Therapy in NSCLC: Improvements in Molecular Testing

EP. 2: Targeted Therapy in NSCLC: Improvements in Molecular Testing

Targeted Oncology
May 27th 2020

Watch

History of KRAS Testing in Advanced NSCLC

EP. 3: History of KRAS Testing in Advanced NSCLC

Targeted Oncology
May 27th 2020

Watch

An Overview of KRAS Tumor Biology

EP. 4: An Overview of KRAS Tumor Biology

Targeted Oncology
May 27th 2020

Watch

KRAS Mutation Subtypes in Advanced NSCLC

EP. 5: KRAS Mutation Subtypes in Advanced NSCLC

Targeted Oncology
May 27th 2020

Watch

Advanced NSCLC: Rationale Behind KRAS Inhibition

EP. 6: Advanced NSCLC: Rationale Behind KRAS Inhibition

Targeted Oncology
May 27th 2020

Watch

KRAS-Mutant NSCLC: Current Systemic Treatment Options

EP. 7: KRAS-Mutant NSCLC: Current Systemic Treatment Options

Targeted Oncology
May 27th 2020

Watch

Impact of Coalterations on KRAS-Mutant NSCLC

EP. 8: Impact of Coalterations on KRAS-Mutant NSCLC

Targeted Oncology
May 27th 2020

Watch

KRAS G12C Inhibition in Advanced NSCLC: AMG 510

EP. 9: KRAS G12C Inhibition in Advanced NSCLC: AMG 510

Targeted Oncology
May 27th 2020

Watch

Practical Considerations for AMG 510 in KRAS-Mutant NSCLC

EP. 10: Practical Considerations for AMG 510 in KRAS-Mutant NSCLC

Targeted Oncology
May 27th 2020

Watch

KRAS G12C Inhibition in Advanced NSCLC: MRTX849

EP. 11: KRAS G12C Inhibition in Advanced NSCLC: MRTX849

Targeted Oncology
May 27th 2020

Watch

KRAS G12C Inhibitors: Acquired Resistance and Combo Strategies

EP. 12: KRAS G12C Inhibitors: Acquired Resistance and Combo Strategies

Targeted Oncology
May 27th 2020

Watch

Future Directions in Managing KRAS-Mutant Advanced NSCLC

EP. 13: Future Directions in Managing KRAS-Mutant Advanced NSCLC

Targeted Oncology
May 27th 2020

Watch